McKay, R
Haider, B
Duh, M S
Valderrama, A
Nakabayashi, M
Fiorillo, M
Ristovska, L
Wen, L
Kantoff, P
Article History
Received: 24 October 2016
Revised: 30 December 2016
Accepted: 9 January 2017
First Online: 21 February 2017
Competing interests
: RM, MN and MF were employed by the Dana-Farber Cancer Institute (DFCI) at the time of the study. RM is currently employed by Moores Cancer Center and University of California. PK, currently employed by Memorial Sloan Kettering Cancer Center, was an employee of the DFCI at the time of the study. PK has served as a consultant to Astellas, Bayer, Janssen, Millennium/Prometrika, Pfizer and Sanofi. RM has received institutional research funding from Bayer and Pfizer. MSD and BH are employees of Analysis Group, a consulting company that has received research grants from Bayer, including one for the current study. LR was an employee of the Analysis Group at the time of the study. AV and LW are employees of Bayer Healthcare, and LW owns Bayer stock. The remaining authors declare no conflict of interest.